Wang, Na
Xu, Xinzhi
Zhong, Yizhe
Wan, Yujie
Hong, Ruixia
Wang, Qizhi
Tang, Jia
Gong, Jiaqi
Zhou, Hang
Li, Fang
Funding for this research was provided by:
NATURAL SCIENCE FOUNDATION OF CHONGQING, CHINA (CSTB2024NSCQ-MSX0647, CSTB2024NSCQ-MSX0460, CSTB2022NSCQ-MSXC324)
CHINA POSTDOCTORAL SCIENCE FOUNDATION (2023M740439)
FUNDAMENTAL RESEARCH FUNDS FOR THE CENTRAL UNIVERSITIES (2023CDJYGRH-ZD02)
CHONGQING SCIENCE AND HEALTH JOINT MEDICAL RESEARCH KEY PROJECT (2025ZDXM015)
Article History
Received: 30 December 2024
Accepted: 11 April 2025
First Online: 24 April 2025
Declarations
:
: The human tissue study was approved by the Ethics Committee of the Chongqing University Affiliated Cancer Hospital, with the ethics approval number CZLS2025019-A. Our study adhered to the Declaration of Helsinki. Regarding patient informed consent, based on our research protocol, the Ethics Committee of Chongqing University Cancer Hospital has determined that obtaining informed consent from patients is not required.All procedures involving the use of experimental animals were approved by the Ethics Committee of the Chongqing University Affiliated Cancer Hospital, with the ethics approval number CZLS2024241-A.
: Not applicable.
: The authors declare no competing interests.